Authors
Latest:
In DOJ Crosshairs: Rethinking Commission-Based Deals With Independent ContractorsPharma companies should review their commission-based compensation arrangements with independent contractors to address enforcement risk under the Anti-Kickback Statute, in light of recent Department of Justice enforcement.
Latest:
What Do Pharma Marketers Need to Know About Voice?Pharma marketers can use their "voice" to increase prominence in advertising.
Latest:
Why Pharma Must Invest in Key Account Management CapabilitiesThe emergence of organized customers demands investment in advanced solutions and next-generation key account management.
Latest:
Drug Manufacturers Take A Fresh Look as PAPs Continue to Hold SpotlightPatient Assistance Programs (PAPs) came out of the shadows in 2020 as several factors aligned that increased demand and awareness of these programs.
Latest:
Silver Linings of a Global Health Crisis: A New Path Forward for Pharma Media Professionalsat some point, we won’t be seeing wall-to-wall COVID coverage anymore, but stories about the fallout. How can pharmaceutical brands prepare for what’s next?
Latest:
Tapping Compliance Data to Drive SuccessHow pharma leaders can convert data collected for compliance purposes from a cost center into a critical success factor.
Latest:
The Future of Launch Excellence is Generative AIHow drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.
Latest:
Gaining Payer Attention Through Digital InnovationIn this case study, learn how to increase payer engagement, drive awareness, monitor competition, and leverage insights to enhance strategic plans and launch success.
Latest:
Changing the Digital Health Playing Field: A New EraThe shift to clinical-grade support offers great opportunity.
Latest:
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to StartBy demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.
Latest:
Drug Diversion in Healthcare is a National Problem, but Recent Survey Shows a Promising Path ForwardHealthcare organizations can lower their risk of drug diversion by strengthening staffing, employee training, and technology.
Latest:
This is Your Wake-Up Call–Sunshine Act Enforcement is HereMitigating potential risk for stakeholders in light of latest Sunshine Act developments.
Latest:
Virtual’s Long-View Reality: Future Priorities and PerspectivesTelemedicine is definitely here to stay, but recent study may offer clues on its sustaining power.
Latest:
Aspiring for the C-Suite? Consider Being a Chief of StaffWhy this role provides a critical ‘boot camp’ for future pharma leaders.
Latest:
Beyond Images: 2024 Trends Reshaping Healthcare with RadiopharmaceuticalsBy capitalizing on AI advancements, pushing the boundaries of personalized medicine with theranostics, and strengthening digital healthcare networks, radiopharmaceuticals are poised to transform healthcare from a reactive to a proactive discipline.
Latest:
Sustainability Sea Change: The Top 5 ESG Challenges for PharmaOutlining the most important sustainability-related hurdles facing leading biopharma companies today—and current efforts underway to meet new expectations in advancing this strategic mandate.
Latest:
Keys to Success for Social Media in Healthcare AdvertisingHow to build a loyal audience of brand evangelists.
Latest:
Teamwork for Better Healthcare Solutions: Merging Clinical and Marketing EffortsIn the ever-evolving landscape of healthcare, it's vital for organizations to take steps toward bridging the gap between their clinical and marketing teams.
Latest:
CRISPR: Maximizing this Revolutionary Genetic Tool While Minimizing IP RiskNew technology serves as reminder for the appropriate uses of CRISPR.
Latest:
Accelerate Pharmaceutical Discovery with End-to-End Scientific Informatics PlatformPerkinElmer Informatics’ Signals Solution Addresses Needs of Research and Clinical Scientists
Latest:
The Importance of Imaging and Centralized Review in Clinical TrialsImaging is an integral part of many clinical studies, particularly in the fields of oncology and ophthalmology. Learn why imaging and centralized review are essential for clinical trials, how to address challenges that arise in these studies, and the advantages of partnering with MERIT in this video.
Latest:
Building Healthcare Consumers’ Trust in Personalized Digital and Data-Led ServicesThe next few years will require life science companies to bring consumer-facing digital services to the core of their corporate competence, rather than leaving it at the periphery of their business capabilities.
Latest:
Accelerating New Medicines: Innovation and Technology at CuriaCuria is proud to partner with pharma and biotech companies to make new medicines that save lives. In order to be able to do that, Curia needs to be constantly innovating. In this podcast, you will learn from Curia’s VP of Portfolio and Sourcing, James Grabowski, about Curia’s small and large molecules most recent technologies, and capabilities.
Latest:
Beyond the Data: Is Blockchain the Answer to Improving Global Health?The COVID-19 pandemic has shifted the adoption of digital platforms in pharma and has made the industry reconsider which technologies can improve global health moving forward.
